Ultrasound Historical Financial Summary
Outlook
Organic Revenue
Growth*
2022E-a)
MSD
•
Adjusted EBIT*
$2.7B+
(equal to $2.6B+ on GE basis)
FCF*
$1.8 - 2.0B
(equal to $2.1 to $2.3B on GE basis)
(GE HealthCare
• Continued order book growth
Greater components access and increased fulfillment
•
Proactive cost and price actions
• Volume growth and productivity
• Inventory build for ramp in demand
Focused working capital improvements
On Track to Finish 2022 with Solid Performance
* Non-GAAP Financial Measure
98
© 2022, General Electric Company. Proprietary information. All rights reserved.
(a- 2022E GEHC figures consistent with GE Company guide for HealthCare segment of MSD organic revenue growth, operating
profit of $2.6B+ and FCF of $2.1-2.3B (after the impact of carve-out adjustments, primarily due to taxes)View entire presentation